共 48 条
- [43] THERAPEUTIC EFFICACY OF COMBINED TREATMENT OF MBL-2 TUMOR-BEARING MICE WITH CYCLOPHOSPHAMIDE (CY), ADOPTIVE TRANSFER OF BONE-MARROW DERIVED MACROPHAGES (M0) AND BIOLOGICAL RESPONSE MODIFIERS (BRMS) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 280 - 280
- [44] Combination of CTLA-4 blockade with anti-CD40/IL-2 immunotherapy augments the CD8+T cell response in resting and tumor-bearing mice JOURNAL OF IMMUNOLOGY, 2010, 184
- [45] T-CELLS FROM LATE TUMOR-BEARING MICE EXPRESS NORMAL LEVELS OF P56(LCK), P59(FYN), ZAP-70, AND CD3-ZETA DESPITE SUPPRESSED CYTOLYTIC ACTIVITY JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (04): : 1029 - 1036
- [46] Increased adiposity reduces the response rate to a combinatorial CTLA-4 based therapy in diet-matched, renal tumor-bearing mice without substantially altering intra-tumoral T cell profiles JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
- [47] AUGMENTATION OF ANTITUMOR IMMUNE-RESPONSE BY TRINITROPHENYL (TNP)-REACTIVE HELPER T-CELLS - ENHANCED INDUCTION OF TUMOR-SPECIFIC LYT-1+2-T-CELL-MEDIATED DELAYED-TYPE HYPERSENSITIVITY FROM SPLEEN-CELLS OF TUMOR-BEARING MICE BY TNP HELPERS JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1986, 77 (06) : 1267 - 1272
- [48] SPECIFIC AND NONSPECIFIC ANTITUMOR IMMUNITY .3. SPECIFIC T-LYMPHOCYTE-MEDIATED CYTOLYSIS OF P815 MASTOCYTOMA AND SL2 LYMPHOMA BY DRAINING LYMPH-NODE CELLS FROM SYNGENEIC TUMOR-BEARING DBA-2J MICE AMERICAN JOURNAL OF PATHOLOGY, 1976, 85 (03): : 661 - 673